10298-81-4

Usage

Uses

Used in Organic Synthesis:
4-Ethoxy-1-fluoro-2-nitrobenzene is utilized as a key intermediate in organic synthesis for the preparation of a variety of functionalized benzene derivatives. Its presence of different functional groups allows for multiple synthetic pathways, making it a valuable component in the creation of complex organic molecules.
Used in Pharmaceutical Research:
In pharmaceutical research, 4-ethoxy-1-fluoro-2-nitrobenzene is employed as a building block for the development of new pharmaceutical compounds. Its unique structure can be leveraged to design and synthesize novel drug candidates with potential therapeutic applications.
Used in Agrochemical Development:
4-Ethoxy-1-fluoro-2-nitrobenzene may also be used in the development of agrochemicals, where its chemical properties can be harnessed to create new pesticides or other agricultural chemicals that can improve crop protection and yield.
Used in Chemical Research:
4-ethoxy-1-fluoro-2-nitrobenzene is also valuable in chemical research for studying the effects of different functional groups on the properties and reactivity of benzene derivatives, contributing to the broader understanding of organic chemistry and its applications.

Upstream product

• 64-67-5 diethyl sulfate 
• 2105-96-6 4-fluoro-3-nitrophenol 
• 75-03-6 ethyl iodide 

Downstream Products

• 1384512-54-2 1-(4-(2,5-difluorobenzyloxy)phenoxy)-4-ethoxy-2-nitrobenzene 

Relevant academic research and scientific papers

High-speed microwave assisted synthesis of SEA0400 - A selective inhibitor of the Na+/Ca2+ exchanger

An efficient and rapid five-step synthesis of SEA0400, a selective Na +/Ca2+ exchanger (NCX) inhibitor, using controlled microwave heating is reported. In addition, a novel three-step route omitting the key Baeyer-Villiger oxidation/

NOVEL TETRAHYDROISOQUINOLINE DERIVATIVE

The present invention relates to a compound or a pharmacologically acceptable salt thereof having an excellent DGAT inhibitory effect and feeding suppressant effect. The present invention provides a compound represented by the general formula (I), or pharmacologically acceptable salt thereof: [wherein, R1 represents a phenylaminocarbonyl group that may be substituted with 1 to 5 group(s) independently selected from Substituent Group A, a benzoxazol-2-yl group that may be substituted with 1 to 3 group(s) independently selected from Substituent Group A, or the like; R2 independently represents a C1-C6 alkyl group; R3 represents a group represented by the formula -C(=O)-O-R4 or the like; R4 represents a hydrogen atom, a C1-C6 alkyl group that may be substituted with 1 to 3 group(s) independently selected from Substituent Group B, or the like; X represents an oxygen atom, a methylene group, or a group represented by the formula -NH-, or the like; L represents a single bond, a methylene group, or the like;...... represents a single bond or a double bond; m represents 1 or 2; n represents an integer of 0 to 5; Substituent Group A represents a halogen atom, a C1-C6 alkyl group, a C1-C6 halogenated alkyl group, a C1-C6 alkoxy group, or the like; and Substituent Group B represents a C3-C6 cycloalkyl group, a phenyl group, a carboxyl group, or the like].